AI Summary Sirolimus (Rapamune) and everolimus (Zortress) are mTOR inhibitors generally used as long-term maintenance therapy to help prevent rejection after liver transplant.
Medically reviewed.
mTOR inhibitors are prescription medications that block a cell pathway called mTOR (mammalian target of rapamycin). Immune cells and cancer cells use this pathway to grow, divide, and multiply. After a liver transplant, blocking the pathway limits the growth of T-cells and B-cells, which are immune cells. This reduces immune damage to the transplanted liver and helps prevent acute and chronic rejection. Sirolimus (Rapamune) and Everolimus (Zortress) are used this way, usually as long-term maintenance therapy. They can also allow lower doses of calcineurin inhibitors such as tacrolimus.
This page explains how sirolimus (Rapamune) and everolimus (Zortress and Afinitor) work, who may benefit, and what to expect during treatment. You can also connect with a liver specialist to discuss whether one of these medications fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
MTOR INHIBITORS OVERVIEW
mTOR inhibitors are prescription medications that block the mTOR pathway, which helps immune cells and cancer cells grow and multiply. After a liver transplant, sirolimus and everolimus lower immune activity to help prevent rejection. Everolimus is also used in cancer care. Treatment plans are personalized based on a person's diagnosis, overall health, and transplant or cancer history.
You can explore each mTOR inhibitor below and see who may benefit from each one. Because the right choice depends on your specific health history, your transplant team or oncology team can help you understand which option fits your care plan.
Sirolimus is an immunosuppressive medication used to help prevent organ rejection after liver transplantation. It blocks cell pathways involved in T-cell growth (T-cells are immune cells). It can serve as an alternative or add-on to calcineurin inhibitors such as tacrolimus. It comes as tablets and as an oral solution.
Explore this therapy:
Everolimus (Zortress) belongs to the same class as sirolimus but has a shorter half-life. Providers commonly use it in combination regimens that reduce exposure to calcineurin inhibitors such as tacrolimus or cyclosporine. It comes as tablets.
Explore this therapy:
Everolimus (Afinitor) is used in oncology for certain cancers. It works by slowing cancer cell growth and reducing tumor proliferation. It is a once-daily tablet.
Explore this therapy:
Transplant recipients who need long-term immunosuppression may benefit, especially when the team wants less calcineurin inhibitor exposure or wants to help preserve kidney function. Afinitor may benefit people with certain advanced or metastatic cancers when their oncology team recommends it.
DAILY HABITS & DIET SUPPORT
mTOR inhibitors work best with steady daily habits. Taking your medicine the same way each day, protecting yourself from infection and sun, and eating and moving in liver-friendly ways all support your care.
Take your medicine exactly as prescribed, without missing doses, at the same time each day. You can take it with or without food, but keep the same routine.
Avoid grapefruit products unless your healthcare provider approves them. Grapefruit can significantly change sirolimus blood levels and can raise everolimus blood levels.
Wash your hands often and follow infection prevention steps. Use sunscreen and protective clothing to reduce skin cancer risk. Avoid live vaccines unless your transplant team approves them. With Afinitor, good oral hygiene can help reduce mouth sores.
After transplant, choose three balanced meals each day with familiar foods you enjoy. Build in gentle movement, such as a short daily walk, and keep every lab and clinic appointment on your calendar.
A nutrition bar designed for liver health can be a simple, consistent way to help meet daily energy and protein goals alongside medication.
Explore Liver Health Nutrition Bars
ROLE IN TRANSPLANT AND CANCER CARE
mTOR inhibitors were developed to suppress immune activity and to slow abnormal cell growth. After liver transplantation, they help protect the new liver from rejection. Everolimus is also used as targeted therapy in certain cancers.
Sirolimus and everolimus are often used as part of a broader medication plan. Your transplant team adjusts that plan over time based on your transplant stability, how well you tolerate each medicine, and your overall health.
Both sirolimus and everolimus reduce immune-mediated injury to the transplanted liver. They help prevent acute and chronic rejection and support long-term graft survival. The graft is the transplanted liver.
Zortress is commonly used with reduced-dose tacrolimus or cyclosporine, which lowers exposure to those calcineurin inhibitors. Rapamune can serve as an alternative or add-on to calcineurin inhibitors. This approach may help preserve kidney function after transplant.
Rapamune and Zortress are generally used as long-term maintenance therapy after liver transplant. Treatment may continue for many years or for life if it is well tolerated and clinically appropriate. Afinitor is generally taken as long as the cancer remains controlled and side effects are manageable.
Common side effects include high cholesterol or triglycerides, mouth sores or ulcers, swelling of the legs or ankles, a higher risk of infection, and slower wound healing. Afinitor can also cause fatigue and rash. Tell your care team about any new symptoms.
TREATMENT MONITORING
Regular monitoring helps your care team see how your body is responding to an mTOR inhibitor and catch changes early. Follow-up usually includes blood tests, and with Afinitor it also includes imaging to check how the cancer is responding.
Your team checks the level of the medicine in your blood and adjusts your dose based on those results. Sirolimus and everolimus levels are both monitored.
Liver and kidney function tests show how your transplanted liver and kidneys are doing on treatment.
Cholesterol and triglycerides can rise on mTOR inhibitors, so your team checks lipid levels and blood counts regularly.
If you take Afinitor, your oncology team schedules imaging studies and lab work to track how the cancer responds to treatment.
Only a qualified healthcare provider can adjust your treatment plan based on your test results and health history.
COMMON QUESTIONS
mTOR inhibitors are prescription medications that block the mTOR pathway, which helps immune cells and cancer cells grow. Sirolimus (Rapamune) and everolimus (Zortress) help prevent organ rejection after liver transplant. Everolimus (Afinitor) is used in oncology for certain cancers. Talk with your care team about whether one of these medications fits your treatment plan.
They block the mTOR pathway, which immune cells use to grow and activate. In transplant care, this limits T-cell growth and reduces immune damage to the transplanted liver. In cancer care, the same pathway slows cancer cell growth and reduces tumor growth signaling.
Transplant recipients who need long-term immunosuppression may benefit, especially when the team wants less calcineurin inhibitor exposure or wants to help preserve kidney function. Afinitor may benefit people with certain advanced or metastatic cancers when their oncology team recommends it. Your care team decides based on your diagnosis and health history.
Common side effects include high cholesterol or triglycerides, mouth sores, swelling of the legs or ankles, a higher infection risk, and slower wound healing. Afinitor can also cause fatigue and rash. Your care team monitors you regularly and can help manage side effects.
No. Avoid grapefruit products unless your healthcare provider approves them. Grapefruit can significantly change sirolimus blood levels and can raise everolimus blood levels. Ask your care team before adding any new food, supplement, or medicine.
Often, yes. Rapamune and Zortress are generally used as long-term maintenance therapy after liver transplant, and treatment may continue for many years or for life if it is well tolerated. Afinitor is generally taken as long as the cancer remains controlled and side effects are manageable. Never stop or change a dose on your own.
Yes. Use sunscreen and protective clothing to reduce skin cancer risk, wash your hands often, and avoid live vaccines unless your transplant team approves them. Attend every scheduled lab test and follow-up visit so your team can keep your treatment safe.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
